on 17 Sep 2024
Last Applicant/ Owned by
One Design Center Pl, Suite 17-500
Boston
MA
02210
Serial Number
88904727 filed on 07th May 2020
Registration Number
7507876 registered on 17th Sep 2024
Correspondent Address
Stephanie H. Bald
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Pharmaceutical research and development services House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, Read More
Pharmaceutical research and development services
31st Jan 2023
31st Jan 2023
House mark for a full line of pharmaceuticals; pharmaceuticals for human use, namely, pharmaceuticals for treatment and prevention of pain and allergic, inflammatory, oncological, autoimmune, genetic, neurological, metabolic, infectious, hematological, musculo-skeletal, degenerative, cardiovascular, respiratory, gastrointestinal, endocrinological, dermatological, genitourinary, ophthalmological, hepatic, and nephrological diseases and conditions mediated via intracellular transport processes
14th Jun 2022
14th Jun 2022
No 88904727
No Service Mark
No 709.0005
No
No
No
No
No
No
No
No
24.15.25 -
Other arrows
26.17.09 -
Curved line(s), band(s) or bar(s)
Status Date | Action Taken |
---|---|
17th Sep 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
17th Sep 2024 | REGISTERED-PRINCIPAL REGISTER |
13th Aug 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
13th Aug 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
10th Jul 2024 | STATEMENT OF USE PROCESSING COMPLETE |
07th Jul 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
30th May 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
29th May 2024 | USE AMENDMENT FILED |
29th May 2024 | SOU EXTENSION 5 FILED |
29th May 2024 | SOU EXTENSION 5 GRANTED |